1. Clinical remission at 52 weeks was similar between ustekinumab and adalimumab. 2. Patient-reported outcomes of stool frequency and abdominal ...
1. Upadacitinib led to significantly greater percentages of clinical remission compared to placebo for both induction and maintenance studies. 2. ...
1. Ozanimod treatment was shown to be more effective at inducing clinical remission than placebo for patients with ulcerative colitis. ...
1. At weeks 10 and 58, more patients in the filgotinib 200 mg group experienced clinical remission compared with the ...
1. Short-term indigo naturalis therapy demonstrated symptomatic improvement in patients with mild to moderate ulcerative colitis. Evidence Rating Level: 1 ...
1. Short-term indigo naturalis therapy demonstrated symptomatic improvement in patients with mild to moderate ulcerative colitis. Evidence Rating Level: 1 ...
Association between antipsychotic use and acute ischemic heart disease in women but not in men: a retrospective cohort study of ...
1. In this randomized controlled trial, patients who received a donor fecal microbiota transplant (FMT) had a higher rate of ...
1. In this randomized controlled trial, patients who received a donor fecal microbiota transplant (FMT) had a higher rate of ...
1. Repeated gastrointestinal infections in mice, in this case Salmonella enterica Typhimurium (ST), caused intestinal tissue inflammation which escalated with ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.